Page last updated: 2024-09-03

2-chloro-n(6)cyclopentyladenosine and cvt 124

2-chloro-n(6)cyclopentyladenosine has been researched along with cvt 124 in 1 studies

Compound Research Comparison

Studies
(2-chloro-n(6)cyclopentyladenosine)
Trials
(2-chloro-n(6)cyclopentyladenosine)
Recent Studies (post-2010)
(2-chloro-n(6)cyclopentyladenosine)
Studies
(cvt 124)
Trials
(cvt 124)
Recent Studies (post-2010) (cvt 124)
2520431820

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, SP; Belardinelli, L; Dennis, D; Milner, P; Olsson, R; Pfister, J; Scammells, PJ; Shryock, JC; Zhang, Y1

Other Studies

1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and cvt 124

ArticleYear
1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 275, Issue:3

    Topics: Adenosine; Adrenergic beta-Antagonists; Animals; Brain; Cell Line; Coronary Vessels; Female; Guinea Pigs; Heart; Male; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Vasodilation; Xanthines

1995